Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
December 2012 Volume 41 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December 2012 Volume 41 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells

  • Authors:
    • Birgitte B. Olsen
    • Tina H. Svenstrup
    • Barbara Guerra
  • View Affiliations / Copyright

    Affiliations: Department of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark, Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark
    Copyright: © Olsen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 1967-1976
    |
    Published online on: September 21, 2012
       https://doi.org/10.3892/ijo.2012.1635
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Glioblastoma multiforme is the most common primary brain tumor and one of the most aggressive types of cancer in adults. Survival signaling and apoptosis resistance are hallmarks of malignant glioma cells. However, recent studies have shown that other types of cell death such as autophagy can be induced in malignant glioma cells. This suggests that stimulation of this process may be explored in new therapeutic strategies against glioblastoma multiforme. Protein kinase CK2 is a highly conserved and constitutively active enzyme that promotes numerous cellular processes such as survival, proliferation and differentiation. CK2 has been found elevated in several malignancies including brain tumors, and to confer resistance against chemotherapeutic agents and apoptotic stimuli. Recently, we have shown that the siRNA-mediated downregulation of CK2 leads to cell death in DNA-PK-proficient human glioblastoma cells. We show, here, that lack of CK2 results in significant induction of autophagic cell death in two human glioblastoma cell lines, M059K and T98G, as indicated by the positive staining of cells with the acidotropic dye acridine orange, and the specific recruitment of microtubule-associated protein 1 light chain 3 (LC3) to autophagosome membranes. Induction of autophagy is accompanied by CK2-dependent decreased phosphorylation of p70 ribosomal S6 and AKT kinases and significantly reduced expression levels of Raptor. In contrast, phosphorylation and activity levels of ERK1/2 are enhanced suggesting an inhibition of the PI3K/AKT/mTORC1 and activation of the ERK1/2 pathways. Furthermore, siRNA-mediated silencing of CK2 results in increased mitochondrial superoxide production in both glioblastoma cell lines. However, mitochondrial reactive oxygen species release correlates with induction of autophagy only in T98G cells. Taken together, our findings identify CK2 as a novel component of the autophagic machinery and underline the potential of its downregulation to kill glioblastoma cells by overcoming the resistance to multiple anticancer agents.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1. 

DN LouisH OhgakiOD WiestlerWK CaveneePC BurgerA JouvetBW ScheithauerP KleihuesThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol11497109200710.1007/s00401-007-0243-417618441

2. 

M VerheijH BartelinkRadiation-induced apoptosisCell Tissue Res301133142200010.1007/s004410000188

3. 

F LefrancJ BrotchiR KissPossible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosisJ Clin Oncol2324112422200510.1200/JCO.2005.03.08915800333

4. 

GC SmithSP JacksonThe DNA-dependent protein kinaseGenes Dev13916934199910.1101/gad.13.8.91610215620

5. 

W ZhuangZ QinZ LiangThe role of autophagy in sensitizing malignant glioma cells to radiation therapyActa Biochim Biophys Sin (Shanghai)41341351200910.1093/abbs/gmp02819430698

6. 

CW WangDJ KlionskyThe molecular mechanism of autophagyMol Med965762003

7. 

EL EskelinenMaturation of autophagic vacuoles in Mammalian cellsAutophagy1110200510.4161/auto.1.1.127016874026

8. 

S PaglinT HollisterT DeloheryN HackettM McMahillE SphicasD DomingoJ YahalomA novel response of cancer cells to radiation involves autophagy and formation of acidic vesiclesCancer Res61439444200111212227

9. 

KC YaoT KomataY KondoT KanzawaS KondoIM GermanoMolecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagyJ Neurosurg98378384200310.3171/jns.2003.98.2.0378

10. 

BB OlsenOG IssingerB GuerraRegulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cellsOncogene2960166026201010.1038/onc.2010.33720711232

11. 

B GuerraOG IssingerProtein kinase CK2 in human diseasesCurr Med Chem1518701886200810.2174/09298670878513293318691045

12. 

NA St-DenisDW LitchfieldProtein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survivalCell Mol Life Sci6618171829200910.1007/s00018-009-9150-219387552

13. 

GM UngerAT DavisJW SlatonK AhmedProtein kinase CK2 as regulator of cell survival: implications for cancer therapyCurr Cancer Drug Targets47784200410.2174/156800904348168714965269

14. 

BB OlsenB GuerraAbility of CK2beta to selectively regulate cellular protein kinasesMol Cell Biochem316115126200810.1007/s11010-008-9817-218560763

15. 

LF PovirkDNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynesMutat Res3557189199610.1016/0027-5107(96)00023-18781578

16. 

F TraganosZ DarzynkiewiczLysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulationsMethods Cell Biol41185194199410.1016/S0091-679X(08)61717-37532261

17. 

A IwamaruY KondoE IwadoH AokiK FujiwaraT YokoyamaGB MillsS KondoSilencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cellsOncogene2618401851200710.1038/sj.onc.120999217001313

18. 

A YamamotoY TagawaT YoshimoriY MoriyamaR MasakiY TashiroBafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cellsCell Struct Funct233342199810.1247/csf.23.33

19. 

D HanahanRA WeinbergThe hallmarks of cancerCell1005770200010.1016/S0092-8674(00)81683-9

20. 

CH JungS-H RoJ CaoNM OttoD-H KimmTOR regulation of autophagyFEBS Lett58412871295201010.1016/j.febslet.2010.01.01720083114

21. 

EA CorcelleP PuustinenM JäätteläApoptosis and autophagy: targeting autophagy signalling in cancer cells -‘trick or treats’FEBS J276608460962009

22. 

RT PetersonPA BealMJ CombSL SchreiberFKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditionsJ Biol Chem27574167423200010.1074/jbc.275.10.741610702316

23. 

J HuangS WuC-L WuBD ManningSignaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressorsCancer Res6961076114200910.1158/0008-5472.CAN-09-0975

24. 

U SivaprasadA BasuInhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cellsJ Cell Mol Med1212651271200810.1111/j.1582-4934.2008.00282.x18266953

25. 

CS HillR MaraisS JohnJ WynneS DaltonR TreismanFunctional analysis of a growth factor-responsive transcription factor complexCell73395406199310.1016/0092-8674(93)90238-L8477450

26. 

X WangGP StudzinskiPhosphorylation of raf-1 by kinase suppressor of ras is inhibited by ‘MEK-specific’ inhibitors PD 098059 and U0126 in differentiating HL60 cellsExp Cell Res2682943002001

27. 

B RavikumarS SarkarJE DaviesM FutterM Garcia-ArencibiaZW Green-ThompsonM Jimenez-SanchezVI KorolchukM LichtenbergS LuoDC MasseyFM MenziesK MoreauU NarayananM RennaFH SiddiqiBR UnderwoodAR WinslowDC RubinszteinRegulation of mammalian autophagy in physiology and pathophysiologyPhysiol Rev9013831435201010.1152/physrev.00030.200920959619

28. 

RK DagdaJ ZhuSM KulichCT ChuMitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson’s diseaseAutophagy4770782200818594198

29. 

Y ChenMB AzadSB GibsonSuperoxide is the major reactive oxygen species regulating autophagyCell Death Differ1610401052200910.1038/cdd.2009.4919407826

30. 

F Nicolau-GalmésA AsumendiE Alonso-TejerinaG Pérez-YarzaS-M JangiJ GardeazabalY Arroyo-BerdugoJM CareagaJL Díaz-RamónA ApraizMD BoyanoTerfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanismsApoptosis1612531267201121861192

31. 

S HuangPJ HoughtonTargeting mTOR signaling for cancer therapyCurr Opin Pharmacol3371377200310.1016/S1471-4892(03)00071-7

32. 

WK WuCW LeeCH ChoFK ChanJ YuJJ SungRNA interference targeting raptor inhibits proliferation of gastric cancer cellsExp Cell Res31713531358201110.1016/j.yexcr.2011.03.00521396933

33. 

GA SolimanHA Acosta-JaquezEA DunlopB EkimNE MajAR TeeDC FingarmTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of actionJ Biol Chem28578667879201010.1074/jbc.M109.09622220022946

34. 

M BreuleuxM KlopfensteinC StephanCA DoughtyL BarysSM MairaD KwiatkowskiHA LaneIncreased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibitionMol Cancer Ther8742753200910.1158/1535-7163.MCT-08-066819372546

35. 

G Di MairaM SalviG ArrigoniO MarinS SarnoF BrustolonLA PinnaM RuzzeneProtein kinase CK2 phosphorylates and upregulates Akt/PKBCell Death Differ12668677200515818404

36. 

JN KreutzerM RuzzeneB GuerraEnhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cellsBMC Cancer10440452201010.1186/1471-2407-10-44020718998

37. 

E Ogier-DenisS PattingreJ Benna ElP CodognoErk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cellsJ Biol Chem2753909039095200010.1074/jbc.M006198200

38. 

AA EllingtonMA BerhowKW SingletaryInhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cellsCarcinogenesis27298306200610.1093/carcin/bgi21416113053

39. 

Y ChengF QiuSI TashiroS OnoderaT IkejimaERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell deathBiochem Biophys Res Commun376483488200810.1016/j.bbrc.2008.09.01818796294

40. 

S CagnolJ-C ChambardERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescenceFEBS J277221200810.1111/j.1742-4658.2009.07366.x19843174

41. 

P SzyniarowskiE Corcelle-TermeauT FarkasM Høyer-HansenJ NylandstedT KallunkiM JaattelaA comprehensive siRNA screen for kinases that suppress macro-autophagy in optimal growth conditionsAutophagy7112201110.4161/auto.7.8.1577021508686

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Olsen BB, Svenstrup TH and Guerra B: Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells. Int J Oncol 41: 1967-1976, 2012.
APA
Olsen, B.B., Svenstrup, T.H., & Guerra, B. (2012). Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells. International Journal of Oncology, 41, 1967-1976. https://doi.org/10.3892/ijo.2012.1635
MLA
Olsen, B. B., Svenstrup, T. H., Guerra, B."Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells". International Journal of Oncology 41.6 (2012): 1967-1976.
Chicago
Olsen, B. B., Svenstrup, T. H., Guerra, B."Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells". International Journal of Oncology 41, no. 6 (2012): 1967-1976. https://doi.org/10.3892/ijo.2012.1635
Copy and paste a formatted citation
x
Spandidos Publications style
Olsen BB, Svenstrup TH and Guerra B: Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells. Int J Oncol 41: 1967-1976, 2012.
APA
Olsen, B.B., Svenstrup, T.H., & Guerra, B. (2012). Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells. International Journal of Oncology, 41, 1967-1976. https://doi.org/10.3892/ijo.2012.1635
MLA
Olsen, B. B., Svenstrup, T. H., Guerra, B."Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells". International Journal of Oncology 41.6 (2012): 1967-1976.
Chicago
Olsen, B. B., Svenstrup, T. H., Guerra, B."Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells". International Journal of Oncology 41, no. 6 (2012): 1967-1976. https://doi.org/10.3892/ijo.2012.1635
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team